267 related articles for article (PubMed ID: 12943482)
1. Strategy to manage the treatment of severe psoriasis: considerations of efficacy, safety and cost.
Feldman SR; Garton R; Averett W; Balkrishnan R; Vallee J
Expert Opin Pharmacother; 2003 Sep; 4(9):1525-33. PubMed ID: 12943482
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of moderate-to-severe psoriasis treatment.
Miller DW; Feldman SR
Expert Opin Pharmacother; 2006 Feb; 7(2):157-67. PubMed ID: 16433581
[TBL] [Abstract][Full Text] [Related]
3. A 61-year-old man with psoriasis.
Baughman RD
JAMA; 1996 Nov; 276(17):1421-8. PubMed ID: 8892718
[No Abstract] [Full Text] [Related]
4. Systemic treatment for moderate to severe psoriasis: estimates of failure rates and direct medical costs in a north-eastern US managed care plan.
Feldman SR; Evans C; Russell MW
J Dermatolog Treat; 2005 Feb; 16(1):37-42. PubMed ID: 15897166
[TBL] [Abstract][Full Text] [Related]
5. Advancements in the treatment of psoriasis: role of biologic agents.
Rich SJ; Bello-Quintero CE
J Manag Care Pharm; 2004; 10(4):318-25. PubMed ID: 15298530
[TBL] [Abstract][Full Text] [Related]
6. Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks.
Naldi L; Griffiths CE
Br J Dermatol; 2005 Apr; 152(4):597-615. PubMed ID: 15840088
[TBL] [Abstract][Full Text] [Related]
7. [Current treatment of psoriasis].
Karvonen J
Duodecim; 2000; 116(24):2769-75; quiz 2776, 2787. PubMed ID: 12077879
[No Abstract] [Full Text] [Related]
8. [Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology].
Beani JC; Jeanmougin M
Ann Dermatol Venereol; 2010 Jan; 137(1):21-31. PubMed ID: 20110064
[TBL] [Abstract][Full Text] [Related]
9. Treatments for psoriasis and the risk of malignancy.
Patel RV; Clark LN; Lebwohl M; Weinberg JM
J Am Acad Dermatol; 2009 Jun; 60(6):1001-17. PubMed ID: 19344980
[TBL] [Abstract][Full Text] [Related]
10. An attempt to formulate an evidence-based strategy in the management of moderate-to-severe psoriasis: a review of the efficacy and safety of biologics and prebiologic options.
Leon A; Nguyen A; Letsinger J; Koo J
Expert Opin Pharmacother; 2007 Apr; 8(5):617-32. PubMed ID: 17376017
[TBL] [Abstract][Full Text] [Related]
11. Psoriasis: current perspectives with an emphasis on treatment.
Linden KG; Weinstein GD
Am J Med; 1999 Dec; 107(6):595-605. PubMed ID: 10625029
[TBL] [Abstract][Full Text] [Related]
12. Phototherapy and photochemotherapy for psoriasis.
Racz E; Prens EP
Dermatol Clin; 2015 Jan; 33(1):79-89. PubMed ID: 25412785
[TBL] [Abstract][Full Text] [Related]
13. Fulfilling an unmet need in psoriasis : do biologicals hold the key to improved tolerability?
Shear NH
Drug Saf; 2006; 29(1):49-66. PubMed ID: 16454534
[TBL] [Abstract][Full Text] [Related]
14. Comparison of clinical and cost-effectiveness of psoralen + ultraviolet A versus psoralen + sunlight in the treatment of chronic plaque psoriasis in a developing economy.
Aggarwal K; Khandpur S; Khanna N; Sharma VK; Pandav CS
Int J Dermatol; 2013 Apr; 52(4):478-85. PubMed ID: 23431966
[TBL] [Abstract][Full Text] [Related]
15. Malignancy concerns with psoriasis treatments using phototherapy, methotrexate, cyclosporin, and biologics: facts and controversies.
Naldi L
Clin Dermatol; 2010; 28(1):88-92. PubMed ID: 20082957
[TBL] [Abstract][Full Text] [Related]
16. Review of home phototherapy.
Rajpara AN; O'Neill JL; Nolan BV; Yentzer BA; Feldman SR
Dermatol Online J; 2010 Dec; 16(12):2. PubMed ID: 21199628
[TBL] [Abstract][Full Text] [Related]
17. Non-invasive evaluation of tacalcitol plus puva versus tacalcitol plus UVB-NB in the treatment of psoriasis: "right-left intra-individual pre/post comparison design".
Brazzelli V; Barbagallo T; Prestinari F; Rona C; De Silvestri A; Trevisan V; Borroni G
Int J Immunopathol Pharmacol; 2005; 18(4):755-60. PubMed ID: 16388725
[TBL] [Abstract][Full Text] [Related]
18. Comparative tolerability of systemic treatments for plaque-type psoriasis.
McClure SL; Valentine J; Gordon KB
Drug Saf; 2002; 25(13):913-27. PubMed ID: 12381213
[TBL] [Abstract][Full Text] [Related]
19. Phototherapy of psoriasis: comparative experience of different phototherapeutic approaches.
Karrer S; Eholzer C; Ackermann G; Landthaler M; Szeimies RM
Dermatology; 2001; 202(2):108-15. PubMed ID: 11306830
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of NBUVB phototherapy and PUVA photochemotherapy in chronic plaque psoriasis.
Dayal S; ; Jain VK
Indian J Dermatol Venereol Leprol; 2010; 76(5):533-7. PubMed ID: 20826993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]